BioCentury
ARTICLE | Deals

With deal to promote CanSino’s vaccine, Pfizer validates Chinese company’s R&D, manufacturing

MNC to promote CanSino’s meningococcal vaccine in China

July 27, 2020 11:54 PM UTC

A deal with Pfizer under which the MNC will promote CanSino’s meningococcal vaccine provides a desired validation for CanSino and China’s newer vaccine companies.

Pfizer Inc. (NYSE:PFE) will exclusively promote the vaccine from CanSino Biologics Inc. (HKEX:6185) following approval by China’s National Medical Products Administration (NMPA). ...